Arshi Rizwan

1.6k total citations · 1 hit paper
14 papers, 1.1k citations indexed

About

Arshi Rizwan is a scholar working on Oncology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Arshi Rizwan has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Arshi Rizwan's work include Cancer Immunotherapy and Biomarkers (5 papers), Peripheral Neuropathies and Disorders (4 papers) and Hereditary Neurological Disorders (4 papers). Arshi Rizwan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Peripheral Neuropathies and Disorders (4 papers) and Hereditary Neurological Disorders (4 papers). Arshi Rizwan collaborates with scholars based in India, United States and Qatar. Arshi Rizwan's co-authors include Mohammad Haris, Muzafar A. Macha, Ajaz A. Bhat, Wael El‐Rifai, Davide Bedognetti, Mayank Singh, Sabah Nisar, Surinder K. Batra, Sheema Hashem and Saife N. Lone and has published in prestigious journals such as Clinical Cancer Research, The Journal of Infectious Diseases and Molecular Cancer.

In The Last Decade

Arshi Rizwan

14 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments

2022 494 citations Saife N. Lone, Sabah Nisar et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arshi Rizwan India	12	492	389	268	169	138	14	1.1k
Srdjan Novaković Slovenia	22	557 1.1×	157 0.4×	292 1.1×	91 0.5×	151 1.1×	114	1.3k
Jeffrey C. Hanson United States	21	590 1.2×	246 0.6×	254 0.9×	210 1.2×	60 0.4×	39	1.2k
Yingmei Li China	20	816 1.7×	407 1.0×	404 1.5×	248 1.5×	119 0.9×	69	1.8k
Aude I. Ségaliny United States	12	648 1.3×	300 0.8×	270 1.0×	94 0.6×	153 1.1×	12	1.2k
Anna Sebestyén Hungary	22	1.1k 2.2×	518 1.3×	464 1.7×	139 0.8×	135 1.0×	103	1.9k
Tonny Lagerweij Netherlands	20	456 0.9×	129 0.3×	209 0.8×	87 0.5×	112 0.8×	33	981
Jennifer Bordeaux United States	16	605 1.2×	192 0.5×	409 1.5×	125 0.7×	60 0.4×	26	1.1k
Yoji Kukita Japan	19	609 1.2×	506 1.3×	424 1.6×	378 2.2×	116 0.8×	68	1.3k
Francesca M. Bosisio Belgium	20	392 0.8×	163 0.4×	330 1.2×	77 0.5×	49 0.4×	53	972

Countries citing papers authored by Arshi Rizwan

Since Specialization

Citations

This map shows the geographic impact of Arshi Rizwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arshi Rizwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arshi Rizwan more than expected).

Fields of papers citing papers by Arshi Rizwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arshi Rizwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arshi Rizwan. The network helps show where Arshi Rizwan may publish in the future.

Co-authorship network of co-authors of Arshi Rizwan

This figure shows the co-authorship network connecting the top 25 collaborators of Arshi Rizwan. A scholar is included among the top collaborators of Arshi Rizwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arshi Rizwan. Arshi Rizwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Lone, Saife N., Sabah Nisar, Tariq Masoodi, et al.. (2022). Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. Molecular Cancer. 21(1). 79–79. 494 indexed citations breakdown →

Bhat, Ajaz A., Nissar Ahmad Wani, Arshi Rizwan, et al.. (2021). Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Signal Transduction and Targeted Therapy. 6(1). 4 indexed citations

Bhat, Ajaz A., Sabah Nisar, Selma Maacha, et al.. (2021). Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. Molecular Cancer. 20(1). 2–2. 106 indexed citations

Nisar, Sabah, Ajaz A. Bhat, Mayank Singh, et al.. (2021). Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies. Frontiers in Cell and Developmental Biology. 9. 617281–617281. 68 indexed citations

Bhat, Ajaz A., Nissar Ahmad Wani, Arshi Rizwan, et al.. (2021). Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Signal Transduction and Targeted Therapy. 6(1). 12–12. 113 indexed citations

Nisar, Sabah, Ajaz A. Bhat, Sheema Hashem, et al.. (2020). Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer. Journal of Translational Medicine. 18(1). 471–471. 18 indexed citations

Rizwan, Arshi & M. D. Ray. (2020). Abstract B79: Effect of HIPEC on immune microenvironment in epithelial ovary cancer. Clinical Cancer Research. 26(13_Supplement). B79–B79. 1 indexed citations

Haris, Mohammad, Santosh K. Yadav, Arshi Rizwan, et al.. (2015). Molecular magnetic resonance imaging in cancer. Journal of Translational Medicine. 13(1). 313–313. 74 indexed citations

Haris, Mohammad, Santosh K. Yadav, Arshi Rizwan, et al.. (2015). T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease. NeuroImage Clinical. 7. 598–604. 27 indexed citations

10.

Nyati, Kishan Kumar, Kashi Nath Prasad, Arshi Rizwan, Avantika Verma, & Vimal Kumar Paliwal. (2011). TH1 and TH2 Response to Campylobacter jejuni Antigen in Guillain-Barré Syndrome. Archives of Neurology. 68(4). 445–445. 51 indexed citations

11.

Verma, Avantika, Kashi Nath Prasad, Rakesh Gupta, et al.. (2010). Toll‐Like Receptor 4 Polymorphism and Its Association with Symptomatic Neurocysticercosis. The Journal of Infectious Diseases. 202(8). 1219–1225. 61 indexed citations

12.

Prasad, Kashi Nath, Kishan Kumar Nyati, Avantika Verma, Arshi Rizwan, & Vimal Kumar Paliwal. (2010). Tumor necrosis factor–α polymorphisms and expression in Guillain–Barré syndrome. Human Immunology. 71(9). 905–910. 27 indexed citations

13.

Nyati, Kishan Kumar, Kashi Nath Prasad, Arshi Rizwan, et al.. (2010). Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome. Medical Microbiology and Immunology. 199(2). 109–116. 14 indexed citations

14.

Nyati, Kishan Kumar, Kashi Nath Prasad, Avantika Verma, et al.. (2009). Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population. Journal of Neuroimmunology. 218(1-2). 116–119. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact